Dimensional Fund Advisors
SLDB icon

Dimensional Fund Advisors’s Solid Biosciences SLDB Stock Holding History

Dimensional Fund Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
1,266,290
+310,155
+32% +$2.35M ﹤0.01% 2208
2026
Q1 		$6.88M Buy
956,135
+277,051
+41% +$1.78M ﹤0.01% 2392
2025
Q4 		$3.83M Buy
679,084
+235,543
+53% +$1.28M ﹤0.01% 2598
2025
Q3 		$2.74M Buy
443,541
+221,203
+99% +$1.29M ﹤0.01% 2689
2025
Q2 		$1.08M Sell
222,338
-47,143
-17% -$167K ﹤0.01% 2872
2025
Q1 		$998K Buy
269,481
+5,412
+2% +$23.2K ﹤0.01% 2884
2024
Q4 		$1.06M Buy
264,069
+192,714
+270% +$1.06M ﹤0.01% 2902
2024
Q3 		$498K Buy
71,355
+528
+0.7% +$4.28K ﹤0.01% 3041
2024
Q2 		$402K Buy
70,827
+5,287
+8% +$47.4K ﹤0.01% 3058
2024
Q1 		$873K Buy
65,540
+15,590
+31% +$146K ﹤0.01% 2944
2023
Q4 		$307K Sell
49,950
-5,140
-9% -$16.4K ﹤0.01% 3128
2023
Q3 		$139K Sell
55,090
-7,074
-11% -$27.4K ﹤0.01% 3275
2023
Q2 		$326K Buy
62,164
+5,829
+10% +$32.8K ﹤0.01% 3145
2023
Q1 		$267K Buy
+56,335
New +$339K ﹤0.01% 3149
2022
Q2 		– Sell
-1,023
Closed -$18K – 3522
2022
Q1 		$18K Sell
1,023
-3,208
-76% -$56.6K ﹤0.01% 3504
2021
Q4 		$111K Hold
4,231
– – ﹤0.01% 3424
2021
Q3 		$152K Hold
4,231
– – ﹤0.01% 3381
2021
Q2 		$232K Sell
4,231
-764
-15% -$50.5K ﹤0.01% 3310
2021
Q1 		$416K Hold
4,995
– – ﹤0.01% 3174
2020
Q4 		$568K Hold
4,995
– – ﹤0.01% 3076
2020
Q3 		$152K Buy
4,995
+353
+8% +$13.5K ﹤0.01% 3230
2020
Q2 		$204K Buy
4,642
+3,336
+255% +$139K ﹤0.01% 3209
2020
Q1 		$47K Hold
1,306
– – ﹤0.01% 3323
2019
Q4 		$87K Hold
1,306
– – ﹤0.01% 3325
2019
Q3 		$203K Hold
1,306
– – ﹤0.01% 3281
2019
Q2 		$113K Buy
+1,306
New +$142K ﹤0.01% 3384

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's SLDB Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Solid Biosciences (SLDB) stake by 32% in Q2 2026, buying an estimated $2.35M and bringing the position to 1,266,290 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Dimensional Fund Advisors first reported a position in SLDB in Q2 2019 and has held it in 26 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Dimensional Fund Advisors held 1,266,290 shares of Solid Biosciences worth $12.6M as of Q2 2026.
  • Dimensional Fund Advisors bought 310,155 Solid Biosciences shares in Q2 2026, an estimated $2.35M.
  • Solid Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2208 holding.
  • Dimensional Fund Advisors first reported a position in Solid Biosciences in Q2 2019 and has held it in 26 quarters since.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.